title: Company profile: PGXIS Ltd.
abstract: Pharmacogenomic Innovative Solutions Ltd (PGXIS) was established in 2007 by a group of pharmacogenomic (PGx) experts to make their expertise available to biotechnology and pharmaceutical companies. PGXIS has subsequently established a network of experts to broaden its access to relevant PGx knowledge and technologies. In addition, it has developed a novel multivariate analysis method called Taxonomy3 which is both a data integration tool and a targeting tool. Together with siRNA methodology from CytoPathfinder Inc., PGXIS now has an extensive range of diverse PGx methodologies focused on enhancing drug development.
authors.affiliation: PGXIS Ltd, Aston Court, Kingsmead Business Park, Frederick Place, High Wycombe, Bucks HP111LA, UK. alun.mccarthy@pgxis.com
authors.forename: Alun
authors.initials: A
authors.lastname: McCarthy
mesh_terms: D054316:Biomarkers, Pharmacological; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000191:economics / Q000941:ethics; D004345:Drug Industry / Q000193:education / Q000941:ethics; D006801:Humans; D058990:Molecular Targeted Therapy; D010597:Pharmacogenetics / Q000941:ethics / Q000639:trends*; D057285:Precision Medicine; D012106:Research / Q000193:education*
chemical_list: D054316:Biomarkers, Pharmacological